• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, November 18, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Very-low-carb diet shows promise in type 1 diabetes

Bioengineer by Bioengineer
May 7, 2018
in Health
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Very-low-carbohydrate diets can improve blood sugar control in type 1 diabetes, with low rates of hypoglycemia and other complications, according to an online patient survey. The researchers, led by Belinda Lennerz, MD, PhD, and David Ludwig, MD, PhD, of Boston Children's Hospital, now call for controlled clinical trials of this approach.

Findings were reported today in the journal Pediatrics.

The patients were drawn from TypeOneGrit, a Facebook community of people with type 1 diabetes committed to a very-low-carb diet as recommended by the book Dr. Bernstein's Diabetes Solution (Richard Bernstein, MD, is a co-author on the study).

Of 493 people who took the survey, 316 provided enough information to be included in the analysis. For 138 of these participants, the researchers were able to confirm diabetes diagnosis, blood-sugar control measures, metabolic health measures and other outcomes with health care providers or through review of medical records. Forty-two percent of participants were children.

Participants reported an average daily carbohydrate intake of 36 grams, or about 5 percent of total calories (for comparison, the American Diabetes Association recommends about 45 percent of calories come from carbohydrates). Self-reported hemoglobin A1c values — the primary measure of blood-sugar control — averaged in the normal range, at 5.67 percent (the target is below 7 percent and prevailing levels average 8.2 percent).

Participants required lower-than-average doses of insulin (mean, 0.40 U/kg/day), and those for whom data were available had favorable measures of insulin sensitivity and cardiometabolic health, such as low triglyceride levels and high HDL cholesterol levels.

Low-carb controversy

Safety concerns have been raised about very-low-carb diets in type 1 diabetes, primarily that they increase the risk of hypoglycemia, or dangerous drops in blood sugar. However, in the study, rates of hospitalization for hypoglycemia (1 percent), diabetic ketoacidosis (2 percent) and other diabetes complications were lower than those generally reported for type 1 diabetes populations.

More than 80 percent of survey respondents were satisfied or very satisfied with their diabetes management. Yet about a quarter said they did not discuss the very-low-carb diet with their diabetes care providers, some citing concerns about being criticized or even being accused of child abuse.

The study authors note that severe carbohydrate restriction is actually a very old approach in type 1 diabetes.1 Before the discovery of insulin, it extended children's lives, sometimes for years. Once insulin was introduced, carb restriction fell out of practice.

But the authors believe very-low-carbohydrate diets deserve further study in type 1 diabetes. Since this study was observational in nature and not controlled, they call for randomized clinical trials to rigorously test the diet's safety and efficacy.

Lennerz and Ludwig emphasize that the results of this study, by themselves, do not justify a change in diabetes management. They strongly suggest that anyone with diabetes make dietary changes only with the supervision of a diabetes care provider.

###

The study is registered at ClinicalTrials.gov. Lennerz and Ludwig are both affiliated with the Division of Endocrinology and New Balance Foundation Obesity Prevention Center at Boston Children's Hospital and Harvard Medical School. The study was supported by the NIH National Institute of Diabetes and Digestive and Kidney Diseases (K24DK082730, K12DK094721).

1 Newburgh LH, Marsh PL. The use of a high fat diet in the treatment of diabetes mellitus. Arch Intern Med 1921; 27(6):699-705

About Boston Children's Hospital

Boston Children's Hospital, the primary pediatric teaching affiliate of Harvard Medical School, is home to the world's largest research enterprise based at a pediatric medical center. Its discoveries have benefited both children and adults since 1869. Today, more than 3,000 scientists, including 8 members of the National Academy of Sciences, 17 members of the National Academy of Medicine and 11 Howard Hughes Medical Investigators comprise Boston Children's research community. Founded as a 20-bed hospital for children, Boston Children's is now a 415-bed comprehensive center for pediatric and adolescent health care. For more, visit our Vector and Thriving blogs and follow us on social media @BostonChildrens, @BCH_Innovation, Facebook and YouTube.

Media Contact

Andrea Duggan
[email protected]
617-919-3110
@BostonChildrens

http://www.childrenshospital.org/newsroom

http://dx.doi.org/10.1542/peds.2017-3349

Share12Tweet7Share2ShareShareShare1

Related Posts

Mapping EGFR Neighborhoods Post-Ligand Activation with MultiMap

November 18, 2025

Cultural Adaptation in Autism Services: A Study

November 18, 2025

Stable Brain Imaging of Pancreatic Islets in Mice

November 18, 2025

Weighing Early GLP-1 and SGLT-2 Diabetes Treatments

November 18, 2025
Please login to join discussion

POPULAR NEWS

  • ESMO 2025: mRNA COVID Vaccines Enhance Efficacy of Cancer Immunotherapy

    211 shares
    Share 84 Tweet 53
  • New Research Unveils the Pathway for CEOs to Achieve Social Media Stardom

    201 shares
    Share 80 Tweet 50
  • Scientists Uncover Chameleon’s Telephone-Cord-Like Optic Nerves, A Feature Missed by Aristotle and Newton

    118 shares
    Share 47 Tweet 30
  • Neurological Impacts of COVID and MIS-C in Children

    89 shares
    Share 36 Tweet 22

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Timing of Palliative Care Influences Cancer Outcomes

Mapping EGFR Neighborhoods Post-Ligand Activation with MultiMap

Boosting Psychological Capital Through Animated Storytelling: A Study

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 69 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.